Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Approvals Analysis: Abbott Leads Another Strong Month For Novel Approvals

Sep 13 2017

• By David Filmore

FDA approved background, 3D rendering, blue street sign

Related Content

Abbott Pulls Absorb Stent Off The Market, Citing Low Sales

Sep 08 2017

US Approvals Analysis: 2016 Another Record Year For FDA Novel Device Approvals

Jan 13 2017

Next-Gen HeartMate Launches In St. Jude's Portfolio

Oct 13 2015

Medtronic Set To Compete With Abbott/St Jude In VADs After Buying HeartWare

Jun 28 2016

Celgene, Agios Ready For Enasidenib Launch After Early Approval

Aug 01 2017

Related Companies

Abbott

Medtronic plc

Bristol Myers Squibb Company

Agios Pharmaceuticals, Inc.

Abbott

Bioventus Inc.

NxStage Medical, Inc.

Globus Medical Inc.

Additional Topics

United States Approvals Innovation Research & Development Medical Device

More from Approvals

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window